SoCal Biosciences is a CRO with over 3 decades of collective experience (10+ years of experience with RNA-based therapeutics) and expertise in bioanalytical assays for mRNA, oligonucleotides, and large molecules. We provide state-of-the-art bioanalytical support for your research and drug development needs, including new drug candidate screening, bio distribution studies (RNA platforms), pharmacokinetic, pharmacodynamic, immunogenicity, and biomarker assays.
Our mission is to redefine bioanalytical services by directly addressing the common challenges faced by the industry. Founded by Dr. Patty Limphong, we are driven by a commitment to efficiency, expertise, and genuine partnership. We focus on solving key pain points:

Delivering timely, high-quality results to meet your project deadlines.
Providing specialized knowledge in RNA, protein, and lipid bioanalytical assay development and optimization.
Setting realistic expectations and consistently delivering on promises.
Assembling a highly skilled technical team to ensure exceptional project handling.
Building strong relationships to support interactions with Health Authorities, investors, and other external audiences.
Our dedication to these principles ensures that we provide innovative, reliable solutions, making SoCal Biosciences your trusted partner in bioanalytical services.
Collaborate with a team of experts who understand the intricacies of your project to select the most reliable methodologies with quality SOPs. Our bioanalytical laboratories are equipped with state-of-the-art technology platforms designed to meet your specific requirements and critical deadlines. All data is carefully reviewed by experienced scientists and management to ensure integrity and accuracy before release, guaranteeing high quality results every time.
With over 20 years of experience in drug discovery and development, SoCal Biosciences delivers end-to-end services to meet your project’s needs across different therapeutic areas. Our areas of focus include, but are not limited to: